Research Output per year
Personal profile
Education/Academic qualification
Doctor of Philosophy (PhD), The University of Western Australia
Bachelor of Medicine and Bachelor of Surgery (MBBS), Cairo University
External positions
Medical Oncologist, St John of God Subiaco Hospital
Dec 2015 → …Medical Oncologist, Linear Clinical Research
Apr 2014 → …Medical Oncologist, Sir Charles Gairdner Hospital
27 Jan 2014 → …Keywords
- Medicine and Pharma
- Gynaecological Cancers
- Melanoma
- Clinical Trials
- Tumour Immunology
- Immunotherapy
Fingerprint Dive into the research topics where Tarek Meniawy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 23 Similar Profiles
Melanoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Ovarian Neoplasms
Medicine & Life Sciences
DNA
Medicine & Life Sciences
Circulating Neoplastic Cells
Medicine & Life Sciences
Safety
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Biomarkers
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2010 2020
Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante, D-B., Calapre, L., Ziman, M., Meniawy, T. & Gray, E. S., 1 Jan 2020, In : Cancer Letters. 468, p. 59-71 13 p.Research output: Contribution to journal › Short survey
Open Access
Circulating Neoplastic Cells
Ovarian Neoplasms
Biopsy
DNA
Neoplasms
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
Heinhuis, K. M., Carlino, M., Joerger, M., Di Nicola, M., Meniawy, T., Rottey, S., Moreno, V., Gazzah, A., Delord, J-P., Paz-Ares, L., Britschgi, C., Schilder, R. J., O'Byrne, K., Curigliano, G., Romano, E., Patah, P., Wang, R., Liu, Y., Bajaj, G. & Siu, L. L., Jan 2020, In : JAMA Oncology. 6, 1, p. 100-107 8 p.Research output: Contribution to journal › Article
Tumor Necrosis Factor Receptors
Glucocorticoids
Clinical Trials
Safety
Neoplasms
Combined ipilimumab and nivolumab first-line and after BRAF-targeted therapy in advanced melanoma
Mason, R., Dearden, H. C., Nguyen, B., Oon, J. S., Smith, J. L., Randhawa, M., Mant, A., Warburton, L., Lo, S., Meniawy, T., Guminski, A., Parente, P., Ali, S., Haydon, A., Long, G. V., Carlino, M. S., Millward, M., Atkinson, V. G. & Menzies, A. M., 6 Oct 2019, In : Pigment Cell and Melanoma Research.Research output: Contribution to journal › Article
Mitogen-Activated Protein Kinase Kinases
Melanoma
Proto-Oncogene Proteins c-akt
Protein-Serine-Threonine Kinases
Therapeutics
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
Calapre, L., Giardina, T., Robinson, C., Reid, A. L., Al-Ogaili, Z., Pereira, M. R., McEvoy, A. C., Warburton, L., Hayward, N. K., Khattak, M. A., Meniawy, T. M., Millward, M., Amanuel, B., Ziman, M. & Gray, E. S., Feb 2019, In : Molecular Oncology. p. 171-184 14 p.Research output: Contribution to journal › Article
Open Access
Melanoma
DNA
Mutation
Neoplasms
Biopsy
1
Citation
(Scopus)
Monitoring melanoma recurrence with circulating tumor DNA: A proof of concept from three case studies
McEvoy, A. C., Pereira, M. R., Reid, A., Pearce, R., Cowell, L., Al-Ogaili, Z., Khattak, M. A., Millward, M., Meniawy, T. M., Gray, E. S. & Ziman, M., 4 Jan 2019, In : Oncotarget. 10, 2, p. 113-122 10 p.Research output: Contribution to journal › Article
Open Access
Melanoma
Recurrence
DNA
Neoplasms
Physiologic Monitoring